ClinicalTrials.Veeva

Menu

Titanium-prepared Platelet Rich Fibrin Versus Connective Tissue Graft for Management of Type-2 Gingival Recession

R

Rizk Beshir

Status

Completed

Conditions

Gingival Recession

Treatments

Other: SECTG with CAF
Other: T-PRF with CAF

Study type

Interventional

Funder types

Other

Identifiers

NCT06621433
1/1-2023

Details and patient eligibility

About

The aim of the study is to evaluate the effectiveness of using titanium prepared platelet rich fibrin with coronally advanced flap in the treatment of type-2 Cairo gingival recession.

Enrollment

44 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gingival recession type 2 according to Cairo et al (2011).
  • Adequate amount of Attached Gingiva (AG) (2 mm≤ AG).
  • Good oral hygiene (full mouth bleeding score and O'Leary index less than ≤10 % after complete phase I therapy)
  • Clinically thick gingival biotype (1mm < gingival thickness).
  • Anterior esthetic zone.

Exclusion criteria

  • Patients with gingival recession types 1 and 3 according to Cairo et al.
  • Inadequate amount of attached gingiva (AG < 2 mm).
  • Uncooperative patients.
  • Smoking more than 10 cigarettes per day.
  • Patients with known systemic conditions or taking medications that may affect soft tissue healing.
  • Pregnant and lactating women.
  • Patients with parafunctional habits.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

44 participants in 2 patient groups

Coronally advanced flap (CAF) in conjunction with titanium prepared PRF
Experimental group
Treatment:
Other: T-PRF with CAF
CAF in conjunction with subepithelial connective tissue graft (SECTG)
Active Comparator group
Treatment:
Other: SECTG with CAF

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems